Open AccessAssociation of Dexamethasone with Shunt Requirement, Early Disability, and Medical Complications in Aneurysmal Subarachnoid Hemorrhage
Author(s) -
Małgorzata Miller,
Katarina Dakay,
Nils Henninger,
Yunis Mayasi,
Ali Mahta,
Aleksandra Yakhkind,
Anas Hannoun,
Bradford Thompson,
Linda C. Wendell,
Raphael A. Carandang
Publication year - 2020
Publication title -
neurocritical care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.908
H-Index - 74
eISSN - 1556-0961
pISSN - 1541-6933
DOI - 10.1007/s12028-020-01059-2
Subject(s) - medicine , dexamethasone , ventriculitis , external ventricular drain , modified rankin scale , subarachnoid hemorrhage , hydrocephalus , ventriculostomy , anesthesia , incidence (geometry) , meningitis , surgery , ischemic stroke , physics , ischemia , optics
Current guidelines do not support the routine use of corticosteroids in patients with aneurysmal subarachnoid hemorrhage (aSAH). However, corticosteroids use in aSAH has been practiced at some centers by convention. The aim of the study was to determine the incidence of hydrocephalus requiring ventriculoperitoneal shunt (VPS) placement as well as functional outcome on discharge and adverse events attributed to corticosteroids in patients with aSAH treated with different dexamethasone (DXM) treatment schemes.